Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

Within an hour of receiving a covid vaccination in November 2020, Utah preschool teacher Brianne Dressen felt pins and needles through her arms and legs.

Key TakeawaysThe global vaccines market reached USD 87.57 billion in 2024 and is projected to grow to USD 206.78 billion by ...

The reduction in emphasis on the unbiased ascertainment of vaccine safety signals, and redirection toward certain specific ...

Key TakeawaysThe global vaccines market reached USD 87.57 billion in 2024 and is projected to grow to USD 206.78 billion by 2035, representing a robust CAGR of 9.80%.Increasing prevalence of ...

Sanofi’s SNY stock has been trading below its 200-day and 50-day moving averages since early June. On June 23, the stock’s ...

The unnamed 60-year-old sought help from medics in Paris, France after suddenly developing health just four weeks after being jabbed with a Covid vaccine.

Fiserv Inc. (NYSE:FI) is one of the most active stocks to buy according to analysts. On June 17, Fiserv announced a new ...

Amarin signs $175 million Vazkepa deal with Recordati, plans global restructuring and targets $70 million in cost cuts to ...

Fellow big pharma company, Sanofi has also made a number of moves to bolster its R&D pipeline for mRNA vaccines – not least when it stated that it would invest €400 million each year into the ...

The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed by Pfizer and BioNTech, which may offer quicker production and greater efficacy than ...

See the latest AstraZeneca PLC ADR stock price (AZN:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Morningstar brands and products ...